Regarded Solutions
Portfolio strategy

Galena Biopharma: David Battles Goliath

In the war against cancer, much of the fighting is done by some of the smallest of pharmaceutical companies. I believe the reason for this is that they hope to become one of the biggest pharmaceutical companies. Of course very few of them actually make it to the top but some have such a strong pipeline of potentially helpful drugs that they either get taken over by one of the big drug companies or team up with one to become extremely successful.

One such company is Galena Biopharma (NASDAQ:GALE). With a market cap of under $200 million right now, the company is one of the "Davids" to battle "Goliath." With an impressive line up of cancer drugs, I...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details